Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours
1998

Androgens and Breast Tumors: The Role of PSA and GCDFP-15

Sample size: 72 publication Evidence: moderate

Author Information

Author(s): RE Hall, JA Clements, SN Birrell, WD Tilley

Primary Institution: Flinders University of South Australia

Hypothesis

The study investigates the relationship between androgen receptor status and the expression of prostate-specific antigen (PSA) and gross cystic disease fluid protein-15 (GCDFP-15) in primary breast tumors.

Conclusion

PSA and GCDFP-15 expression in breast tumors is dependent on the presence of androgen receptors, but not on estrogen or progesterone receptor status.

Supporting Evidence

  • 85% of breast tumors were found to be AR-positive.
  • 98% of PSA-positive tumors were also AR-positive.
  • PSA immunoreactivity was significantly associated with GCDFP-15 immunoreactivity.

Takeaway

This study found that certain proteins related to androgens are present in many breast tumors, which might help doctors understand how to treat these cancers better.

Methodology

The study used immunohistochemistry to examine the expression of androgen receptors, PSA, and GCDFP-15 in 72 primary breast tumors.

Limitations

The study did not determine tumor grade in five cases and had a relatively small sample size.

Participant Demographics

Median age at operation was 59 years, with a range from 30 to 86 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication